Reciprocal regulation between GCN2 (eIF2AK4) and PERK (eIF2AK3) through the JNK-FOXO3 axis to modulate cancer drug resistance and clonal survival. (2020)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.mce.2020.110932
PubMed Identifier: 32615282
Publication URI: http://europepmc.org/abstract/MED/32615282
Type: Journal Article/Review
Volume: 515
Parent Publication: Molecular and cellular endocrinology
ISSN: 0303-7207